One of the new weekly additions here at The Acquirer’s Multiple features some of the top picks from our All Investable Stock Screener and some top investors that have added, or are holding these same picks in their portfolios. Investors such as Joel Greenblatt, Carl Icahn, Jim Simons, Prem Watsa, Jeremy Grantham, and Howard Marks.
The top investor data is provided from the latest 13F’s over at WhaleWisdom (dated 2017-09-30/2017-12-31). This week we’ll take a look at pick #22 in our All Investable Stock Screener:
Gilead Sciences Inc (NASDAQ:GILD)
Welcome to our latest issue of issue of ValueWalk’s hedge fund update. Below subscribers can find an excerpt in text and the full issue in PDF format. Please send us your feedback! Featuring Andurand's oil trading profits surge, Bridgewater profits from credit, and Tiger Cub Hedge Fund shuts down. Q1 2022 hedge fund letters, conferences Read More
A quick look at the price chart for Gilead shows us that the stock is up 17.6% in the past twelve months. We currently have the stock trading at an Acquirer’s Multiple of 6.84.
Top investors who took new positions in Gilead in the latest reported quarter include:
Rich Pzena – Pzena Asset Management – 2,869 shares
Other top investors who currently hold positions in Gilead in the latest reported quarter include:
Jim Simons – Renaissance Technologies – 401,836 shares
Joel Greenblatt – Gotham Asset Management -696,622 shares
John Rogers – Ariel Investments – 2,169,437 shares
Ken Fisher – Fisher Asset Management – 442,774 shares
For more articles like this, check out our recent articles here.
The post "Acquirer's Multiple Stocks Featuring In Greenblatt, Simons, Pzena Portfolios" appeared first on The Acquirer's Multiple.